Larry Ellison cancels $7.5bn Oracle share sale
Larry Ellison has cancelled a planned $7.5bn sale of Oracle shares, reversing course one day after a filing disclosed plans to sell up to 50mn shares by the end of October. The cancellation removes a near-term source of potential share supply, but the abrupt reversal leaves the market focused on Ellison’s intentions and Oracle’s ability to sustain its growth.
The Financial Times reported on September 12 that Larry Ellison cancelled a planned sale of Oracle shares worth $7.5bn. The decision came one day after a filing revealed that he intended to sell up to 50mn shares by the end of October; the report did not give a reason for the about-face or say whether any shares had already been sold.
Oracle’s latest disclosed annual figures provide a growth backdrop but do not resolve the insider-sale question. Revenue was $67.4bn in the fiscal year ended May 31, 2026, up 17.3% year on year, while net margin was 25.4% and diluted EPS was $5.83.
The direct company link is Ellison’s ownership of Oracle: cancelling the transaction removes the proposed selling pressure from his planned disposition, while Oracle’s operating performance remains tied to revenue growth, profitability and earnings per share. The filing’s proposed scale—up to 50mn shares—made the transaction material, but the reporting does not establish how it would have affected the company’s finances or capital structure.
The cancellation is not the same as a new operating forecast. The Financial Times did not report a change to Oracle’s guidance, results or capital-allocation policy, and it did not explain whether the sale was cancelled permanently or merely postponed. The market therefore has a clear change in the near-term supply setup but limited evidence about Ellison’s underlying rationale.
The next decisive evidence would be Oracle’s next earnings release or a new filing showing whether Ellison resumes, modifies or abandons the sale plan. Until then, the key open questions are why the transaction was reversed and whether the cancellation reflects a changed view of Oracle’s prospects or a non-operating consideration.
The cancelled $7.5bn sale removes a near-term supply overhang for ORCL, but the unexplained reversal limits the bullish read.
The immediate implication is a cleaner near-term share-supply setup for ORCL, while the absence of an explanation prevents a stronger directional call. Oracle’s $67.4B of fiscal 2026 revenue grew 17.3% year on year and net margin was 25.4%, but those figures do not show that the cancellation reflects improved operating expectations rather than a temporary change in Ellison’s plans.
A new filing could show that the sale was only deferred, or disclose a reason unrelated to Oracle’s operating outlook; renewed insider selling would restore the overhang.
CoverageSource: Financial Times · Published here SAT, SEP 12 · 1:18 PM ET · the only report in this recordHow this is decided →
Earlier context and later coverage are dated relative to this report. Automatically linked reports may cover a broader event.
No later reports linked yet.
Follow this story to find new evidence in your Following desk.
The cancellation removes a proposed $7.5bn disposition of up to 50mn shares, while Oracle’s latest annual revenue grew 17.3% year on year.
The Financial Times gave no reason for the reversal, and a postponed sale could recreate the same supply overhang without any change in Oracle’s fundamentals.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →